Immunologic Factor – Page 23

J&J’s Subcutaneous Rybrevant Receives CHMP Backing for Lung Cancer Treatment Despite Recent FDA Rejection

7 months ago talkbio0Tagged amivantamab, CHMP, Epidermal Growth Factor Receptor, Johnson & Johnson, Mutation, Non-Small Cell Lung Carcinoma, Rybrevant, subcutaneous formulation, United States Food and Drug Administration

Rybrevant, amivantamab, Johnson & Johnson, CHMP, FDA, subcutaneous formulation, non-small cell lung cancer, EGFR mutations

RFK Jr.’s HHS Secretary Nomination Advances to Full Senate Vote

7 months ago talkbio0Tagged CHARGE Syndrome, Confirmation, Republican, Robert F. Kennedy, Secretary, Senate Finance Committee, Vaccines

Robert F. Kennedy Jr., HHS Secretary, Senate Finance Committee, confirmation process, vaccine controversy, Republican support

Senator Cassidy’s Crucial Vote Advances RFK Jr.’s HHS Secretary Nomination

7 months ago talkbio0Tagged Administration occupational activities, Bill Cassidy, CHARGE Syndrome, HHS, public health medicine (field), Robert F. Kennedy, Secretary Nomination, Senate Finance Committee, Transplant Registry Unified Management Program, Vaccines

Robert F. Kennedy Jr., Bill Cassidy, HHS Secretary nomination, Senate Finance Committee, vaccine safety, public health, Trump administration

Merck Suspends Gardasil Shipments to China, Lowers 2025 Revenue Forecast

7 months ago talkbio0Tagged Cancer Vaccines, China, Gardasil, Merck, shipment, Suspensions

Merck, Gardasil, China, revenue forecast, cancer vaccine, shipment suspension

AstraZeneca Cancels £450 Million UK Vaccine Plant Expansion Amid Government Funding Reduction

7 months ago talkbio0Tagged Administration occupational activities, AstraZeneca, Drug Industry, Economic Growth, Government, Investments, Labor (Childbirth), Manufacturing, UK, Vaccines

AstraZeneca, vaccine manufacturing, UK investment, government funding, Labour administration, economic growth, pharmaceutical industry

Sanofi’s Beyfortus Achieves Blockbuster Status, Poised for Further Growth in US Market

8 months ago talkbio0Tagged Antibodies, Beyfortus, blockbuster sales, Growth, Infant, Market, Protection, Respiratory syncytial virus, sanofi, U.S.

Beyfortus, RSV antibody, Sanofi, blockbuster sales, US market growth, infant protection, respiratory syncytial virus

J&J’s Rybrevant-Lazcluze Combo Demonstrates Superior Survival Benefit Over Tagrisso in EGFR-Mutated NSCLC

8 months ago talkbio0Tagged chemotherapy-free regimen, Epidermal Growth Factor Receptor, Lazcluze, Mutation, Non-Small Cell Lung Carcinoma, Overall Survival, Phase III MARIPOSA trial, Rybrevant, Tagrisso

Rybrevant, Lazcluze, Tagrisso, NSCLC, EGFR mutation, overall survival, Phase III MARIPOSA trial, chemotherapy-free regimen

Senate Grills RFK Jr. on Controversial Health Stances in Contentious HHS Secretary Confirmation Hearings

8 months ago talkbio0Tagged Administration occupational activities, CHARGE Syndrome, Chronic disease, Confirmation, Hearings, public health policy, Robert F. Kennedy, Secretary Nomination, Senate, Skepticism, Transplant Registry Unified Management Program, Vaccines

Robert F. Kennedy Jr., HHS Secretary nomination, Senate confirmation hearings, vaccine skepticism, chronic disease focus, public health policy, Trump administration

Senate Hearing for RFK Jr. Amid Strong Public Support for Vaccine Access

8 months ago talkbio0Tagged Department of Health and, FDA-approved, Hearing, Homo sapiens, public entity, RFK Jr., Senate, Services, United States Food and Drug Administration, Vaccines

RFK Jr., Senate hearing, vaccine access, public support, FDA-approved vaccines, Department of Health and Human Services nomination

RFK Jr. Faces Intense Scrutiny in Senate Confirmation Hearings for HHS Secretary

8 months ago talkbio0Tagged Confirmation, doubt, Health, Hearings, Human Services Secretary, Republican, Robert F. Kennedy, Senate, stance, Transplant Registry Unified Management Program, Vaccines

Robert F. Kennedy Jr., Senate confirmation hearings, Health and Human Services Secretary, Trump nominee, vaccine stance, Republican doubts